Lisa Nyanda-Manalo, MD
Dermatology · Wesley Chapel, FLNPI 1023187960
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $86,892 of the $109,924 with a category attached, or 79.0%. Galderma Laboratories, L.p. accounts for 79.2% of it on its own, with 38 other manufacturers making up the rest. Reporting peaked in 2023 at $51,214 and has fallen 52.9% since, to $24,133 in 2025. Among dermatology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 498 payments — averaging $220.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$87K
- Novartis$8K
- Dermavant Sciences, Inc.$6K
- AbbVie$2K
- Arcutis Biotherapeutics, Inc.$1K
- Pfizer$758
- plus $5K from 33 others
What the payments were for
- Consulting fees$10,4259%
- Speaking & faculty fees$86,89279%
- Travel & lodging$8341%
- Food & beverage$11,53410%
- Education$2380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$109,924 in reported general payments places this provider in the 90th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 422 | $26,368 |
| Ketoconazole | 905 | $14,526 |
| Metronidazole | 157 | $12,098 |
| Fluorouracil | 74 | $8,219 |
| Clindamycin Phosphate | 286 | $8,006 |
| Pimecrolimus | 28 | $6,509 |
| Tretinoin | 70 | $6,428 |
| Ammonium Lactate | 164 | $4,818 |
| Triamcinolone Acetonide | 315 | $3,729 |
| Hydrocortisone | 382 | $3,136 |
| Fluocinolone Acetonide | 41 | $2,163 |
| Mupirocin | 335 | $1,969 |
| Azelaic Acid | 16 | $1,696 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 19 | $1,402 |
| Doxycycline Hyclate | 173 | $1,256 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Wesley Chapel
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
- Mercedes GonzalezMiami$943K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.